DAVINCI LABORATORIES ISSUES ALLERGY ALERT ON UNDECLARED SHELLFISH ALLERGEN IN AMYLOID COMPLETE PRODUCT LOT 549853001
WILLISTON, Vt., May 8, 2024 /PRNewswire/ -- DaVinci Laboratories, a division of FoodScience, LLC of Williston, Vermont is recalling 72 bottles of Amyloid Complete because it may contain undeclared shellfish (Shrimp and Crab). People who have an allergy or severe sensitivity to shellfish run the risk of serious or life-threatening allergic reaction if they consume these products.
Amyloid Complete product was distributed nationwide through e-commerce (iHerb.com, fullscripts.com) and direct delivery.
Product is contained in a white plastic bottle marked with lot # 549853001 and 0125 expiration date on the side of the label. Amyloid Complete is a capsule that is tan in color.
The issue was identified through a customer complaint which found bottles of Amyloid Complete may contain Perna Plus Tabs with DMG, resulting in undeclared shellfish. No illnesses have been reported to date.
Consumers who are allergic or sensitive to shellfish should not consume this product. Consumers who have purchased DaVinci Laboratories Amyloid Complete Product containing this lot number are urged to contact the company at 1-800-325-1776 M-F 8:30am-5:00pm EST to arrange for return and replacement of product.
Beth Bartlett/1-800-325-1776
DaVinci Laboratories, a division of FoodScience, LLC 929 Harvest Lane Williston, Vermont 05495
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...
YOUR LEGAL RIGHTS MAY BE AFFECTED
There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...
